In addition, the potential biomarkers identified from characteristic metabolites are significantly correlated with the crucial parameters of PAH such as mPAP, PVR and NT-proBNP, which are thus closely related to the diagnosis and prognosis of PAH-CHD. This evidence concerns the gene NPPB and coronary artery disorder.